MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 68 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $5,723,000 | +49.2% | 2,253,118 | +19.3% | 0.29% | -86.5% |
Q1 2020 | $3,835,000 | -34.2% | 1,889,100 | -30.0% | 2.17% | +138.0% |
Q4 2019 | $5,832,000 | -8.5% | 2,700,000 | -34.8% | 0.91% | -8.8% |
Q3 2019 | $6,377,000 | -61.0% | 4,140,819 | +5.1% | 1.00% | -9.4% |
Q2 2019 | $16,354,000 | +1.7% | 3,940,819 | +2.5% | 1.10% | -29.2% |
Q1 2019 | $16,074,000 | +31.5% | 3,845,407 | -9.7% | 1.56% | -37.1% |
Q4 2018 | $12,224,000 | -44.1% | 4,259,367 | +94.7% | 2.47% | +70.4% |
Q3 2018 | $21,874,000 | +11.3% | 2,187,367 | -21.3% | 1.45% | -17.6% |
Q2 2018 | $19,650,000 | +61.3% | 2,779,321 | -12.8% | 1.76% | +49.4% |
Q1 2018 | $12,179,000 | -34.5% | 3,188,221 | +39.9% | 1.18% | -35.3% |
Q4 2017 | $18,595,000 | +18.0% | 2,278,848 | -15.1% | 1.82% | -45.2% |
Q3 2017 | $15,760,000 | +1401.0% | 2,684,848 | +250.3% | 3.32% | +1181.9% |
Q2 2017 | $1,050,000 | -23.5% | 766,448 | -1.1% | 0.26% | -36.8% |
Q1 2017 | $1,372,000 | – | 775,000 | – | 0.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $2,440,000 | 0.40% |
ArrowMark Colorado Holdings LLC | 942,059 | $1,715,000 | 0.03% |
A.R.T. Advisors, LLC | 39,100 | $71,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 52,432 | $95,000 | 0.02% |
Orbimed Advisors | 567,600 | $1,033,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 15,697 | $29,000 | 0.01% |
Palo Alto Investors LP | 63,517 | $116,000 | 0.01% |
Virtu KCG Holdings LLC | 90,063 | $164,000 | 0.00% |
SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $18,000 | 0.00% |
FRANKLIN RESOURCES INC | 2,182,185 | $3,972,000 | 0.00% |